TY - JOUR AU - Jemal, A. AU - Tiwari, R. C. AU - Murray, T. AU - Ghafoor, A. AU - Samuels, A. AU - Ward, E. AU - Feuer, E. AU - Thun, M. PY - 2004 DA - 2004// TI - Cancer statistics, 2004 JO - CA Cancer J Clin VL - 54 UR - https://doi.org/10.3322/canjclin.54.1.8 DO - 10.3322/canjclin.54.1.8 ID - Jemal2004 ER - TY - JOUR AU - Dobson, J. M. AU - Samuel, S. AU - Milstein, H. AU - Rogers, K. AU - Wood, J. L. N. PY - 2002 DA - 2002// TI - Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs JO - J Small Anim Pract VL - 43 UR - https://doi.org/10.1111/j.1748-5827.2002.tb00066.x DO - 10.1111/j.1748-5827.2002.tb00066.x ID - Dobson2002 ER - TY - STD TI - Vail DM, Thamm DH. Spontaneously occurring tumors in companion animals as models for drug development. In: Teicher BA, Andrews PA, editors. Anticancer drug development guide: preclinical screening, clinical trials, and approval. 2nd ed. Totowa: Humana Press; 2004. pp. 259–84. ID - ref3 ER - TY - STD TI - Grüntzig K, Graf R, Hässig M, Welle M, Meier D, Lott G, Erni D, Schenker NS, Guscetti F, Boo G, et al. The Swiss Canine Cancer Registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol. 2015;152:161–71. ID - ref4 ER - TY - JOUR AU - Hosoya, K. AU - Kisseberth, W. C. AU - Lord, L. K. AU - Alvarez, F. J. AU - Lara-Garcia, A. AU - Kosarek, C. E. AU - London, C. A. AU - Couto, C. G. PY - 2007 DA - 2007// TI - Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma JO - J Vet Intern Med VL - 21 UR - https://doi.org/10.1111/j.1939-1676.2007.tb01959.x DO - 10.1111/j.1939-1676.2007.tb01959.x ID - Hosoya2007 ER - TY - JOUR AU - Garrett, L. D. AU - Thamm, D. H. AU - Chun, R. AU - Dudley, R. AU - Vail, D. M. PY - 2002 DA - 2002// TI - Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma JO - J Vet Intern Med VL - 16 UR - https://doi.org/10.1111/j.1939-1676.2002.tb02411.x DO - 10.1111/j.1939-1676.2002.tb02411.x ID - Garrett2002 ER - TY - JOUR AU - MacDonald, V. S. AU - Thamm, D. H. AU - Kurzman, I. D. AU - Turek, M. M. AU - Vail, D. M. PY - 2005 DA - 2005// TI - Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma? JO - J Vet Intern Med VL - 19 UR - https://doi.org/10.1111/j.1939-1676.2005.tb02753.x DO - 10.1111/j.1939-1676.2005.tb02753.x ID - MacDonald2005 ER - TY - STD TI - Facts, 2010-2011. White Plains. NY: Leukemia and Lymphoma Society. p. 2011. ID - ref8 ER - TY - JOUR AU - Johnson, J. I. AU - Decker, S. AU - Zaharevitz, D. AU - Rubinstein, L. V. AU - Venditti, J. M. AU - Schepartz, S. AU - Kalyandrug, S. AU - Christian, M. AU - Arbuck, S. AU - Hollingshead, M. PY - 2001 DA - 2001// TI - Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials JO - Br J Cancer VL - 84 UR - https://doi.org/10.1054/bjoc.2001.1796 DO - 10.1054/bjoc.2001.1796 ID - Johnson2001 ER - TY - JOUR AU - Valli, V. E. AU - San Myint, M. AU - Barthel, A. AU - Bienzle, D. AU - Caswell, J. AU - Colbatzky, F. AU - Durham, A. AU - Ehrhart, E. J. AU - Johnson, Y. AU - Jones, C. PY - 2011 DA - 2011// TI - Classification of canine malignant lymphomas according to the World Health Organization criteria JO - Vet Pathol VL - 48 UR - https://doi.org/10.1177/0300985810379428 DO - 10.1177/0300985810379428 ID - Valli2011 ER - TY - JOUR AU - Breen, M. AU - Modiano, J. F. PY - 2008 DA - 2008// TI - Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans--man and his best friend share more than companionship JO - Chromosom Res VL - 16 UR - https://doi.org/10.1007/s10577-007-1212-4 DO - 10.1007/s10577-007-1212-4 ID - Breen2008 ER - TY - JOUR AU - Fosmire, S. P. AU - Thomas, R. AU - Jubala, C. M. AU - Wojcieszyn, J. W. AU - Valli, V. E. AU - Getzy, D. M. AU - Smith, T. L. AU - Gardner, L. A. AU - Ritt, M. G. AU - Bell, J. S. PY - 2007 DA - 2007// TI - Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma JO - Vet Pathol VL - 44 UR - https://doi.org/10.1354/vp.44-4-467 DO - 10.1354/vp.44-4-467 ID - Fosmire2007 ER - TY - JOUR AU - Thomas, R. AU - Seiser, E. L. AU - Motsinger-Reif, A. AU - Borst, L. AU - Valli, V. E. AU - Kelley, K. AU - Suter, S. E. AU - Argyle, D. AU - Burgess, K. AU - Bell, J. PY - 2011 DA - 2011// TI - Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas JO - Leuk Lymphoma VL - 52 UR - https://doi.org/10.3109/10428194.2011.559802 DO - 10.3109/10428194.2011.559802 ID - Thomas2011 ER - TY - JOUR AU - Honigberg, L. A. AU - Smith, A. M. AU - Sirisawad, M. AU - Verner, E. AU - Loury, D. AU - Chang, B. AU - Li, S. AU - Pan, Z. AU - Thamm, D. H. AU - Miller, R. A. PY - 2010 DA - 2010// TI - The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.1004594107 DO - 10.1073/pnas.1004594107 ID - Honigberg2010 ER - TY - JOUR AU - Kim, N. AU - Park, H. AU - Oh, M. AU - Kim, I. PY - 2013 DA - 2013// TI - Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells JO - BMB Rep VL - 46 UR - https://doi.org/10.5483/BMBRep.2013.46.1.123 DO - 10.5483/BMBRep.2013.46.1.123 ID - Kim2013 ER - TY - JOUR AU - Liu, C. AU - Liu, Z. AU - Li, M. AU - Li, X. AU - Wong, Y. -. S. AU - Ngai, S. -. M. AU - Zheng, W. AU - Zhang, Y. AU - Chen, T. AU - Rameshwar, P. PY - 2013 DA - 2013// TI - Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0053945 DO - 10.1371/journal.pone.0053945 ID - Liu2013 ER - TY - JOUR AU - Beillerot, A. AU - Battaglia, E. AU - Bennasroune, A. AU - Bagrel, D. PY - 2012 DA - 2012// TI - Protection of CDC25 phosphatases against oxidative stress in breast cancer cells: evaluation of the implication of the thioredoxin system JO - Free Radic Res VL - 46 UR - https://doi.org/10.3109/10715762.2012.669039 DO - 10.3109/10715762.2012.669039 ID - Beillerot2012 ER - TY - JOUR AU - Sobhakumari, A. AU - Love-Homan, L. AU - Fletcher, E. V. M. AU - Martin, S. M. AU - Parsons, A. D. AU - Spitz, D. R. AU - Knudson, C. M. AU - Simons, A. L. PY - 2012 DA - 2012// TI - Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0048175 DO - 10.1371/journal.pone.0048175 ID - Sobhakumari2012 ER - TY - STD TI - Guidi F, Landini I, Puglia M, Magherini F, Gabbiani C, Cinellu MA, Nobili S, Fiaschi T, Bini L, Mini E et al: Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds. Metallomics 2012;4:307–14. ID - ref19 ER - TY - JOUR AU - Marzano, C. AU - Gandin, V. AU - Folda, A. AU - Scutari, G. AU - Bindoli, A. AU - Rigobello, M. P. PY - 2007 DA - 2007// TI - Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells JO - Free Radic Biol Med VL - 42 UR - https://doi.org/10.1016/j.freeradbiomed.2006.12.021 DO - 10.1016/j.freeradbiomed.2006.12.021 ID - Marzano2007 ER - TY - JOUR AU - Fath, M. A. AU - Ahmad, I. AU - Smith, C. J. AU - Spence, J. AU - Spitz, D. PY - 2011 DA - 2011// TI - Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0736 DO - 10.1158/1078-0432.CCR-11-0736 ID - Fath2011 ER - TY - JOUR AU - Nakaya, A. AU - Sagawa, M. AU - Muto, A. AU - Uchida, H. AU - Ikeda, Y. AU - Kizaki, M. PY - 2011 DA - 2011// TI - The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity JO - Leuk Res VL - 35 UR - https://doi.org/10.1016/j.leukres.2010.05.011 DO - 10.1016/j.leukres.2010.05.011 ID - Nakaya2011 ER - TY - JOUR AU - Kim, I. AU - Jin, J. AU - Lee, I. AU - Park, S. J. PY - 2004 DA - 2004// TI - Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro JO - Br J Pharmacol VL - 142 UR - https://doi.org/10.1038/sj.bjp.0705708 DO - 10.1038/sj.bjp.0705708 ID - Kim2004 ER - TY - JOUR AU - Liu, J. J. AU - Liu, Q. AU - Wei, H. L. AU - Yi, J. AU - Zhao, H. S. AU - Ga, L. P. PY - 2011 DA - 2011// TI - Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells JO - Pharmazie VL - 66 ID - Liu2011 ER - TY - STD TI - Skalska J, Kiebala M, Maggirwar S, Brookes P, Bernstein SH: The effect of auranofin on lymphoma cells: mechanism of action. Free Radic Biol Med 2011;51:S129-S129. ID - ref25 ER - TY - JOUR AU - Kim, N. AU - Oh, M. AU - Park, H. AU - Kim, I. PY - 2010 DA - 2010// TI - Auranofin, a gold(I)-containing antirheumatic compound, activates Keap1/Nrf2 signaling via Rac1/iNOS signal and mitogen-activated protein kinase activation JO - J Pharmacol Sci VL - 113 UR - https://doi.org/10.1254/jphs.09330FP DO - 10.1254/jphs.09330FP ID - Kim2010 ER - TY - JOUR AU - Stern, I. AU - Wataha, J. C. AU - Lewis, J. B. AU - Messer, R. L. W. AU - Lockwood, P. E. AU - Tseng, W. Y. PY - 2005 DA - 2005// TI - Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion JO - Toxicol in Vitro VL - 19 UR - https://doi.org/10.1016/j.tiv.2004.11.001 DO - 10.1016/j.tiv.2004.11.001 ID - Stern2005 ER - TY - JOUR AU - Han, S. AU - Kim, K. AU - Kim, H. AU - Kwon, J. AU - Lee, Y. H. AU - Lee, C. K. AU - Song, Y. AU - Lee, S. J. AU - Ha, N. PY - 2008 DA - 2008// TI - Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE(2) production in macrophages JO - Arch Pharm Res VL - 31 UR - https://doi.org/10.1007/s12272-008-1122-9 DO - 10.1007/s12272-008-1122-9 ID - Han2008 ER - TY - JOUR AU - Jeon, K. I. AU - Jeong, J. AU - Jue, D. M. PY - 2000 DA - 2000// TI - Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase JO - J Immunol VL - 164 UR - https://doi.org/10.4049/jimmunol.164.11.5981 DO - 10.4049/jimmunol.164.11.5981 ID - Jeon2000 ER - TY - JOUR AU - Kim, N. AU - Lee, M. AU - Park, S. J. AU - Choi, J. AU - Oh, M. AU - Kim, I. PY - 2007 DA - 2007// TI - Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3 JO - Immunology VL - 122 UR - https://doi.org/10.1111/j.1365-2567.2007.02679.x DO - 10.1111/j.1365-2567.2007.02679.x ID - Kim2007 ER - TY - JOUR AU - Brown, K. K. AU - Cox, A. G. AU - Hampton, M. B. PY - 2010 DA - 2010// TI - Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin JO - FEBS Lett VL - 584 UR - https://doi.org/10.1016/j.febslet.2010.02.042 DO - 10.1016/j.febslet.2010.02.042 ID - Brown2010 ER - TY - JOUR AU - Omata, Y. AU - Folan, M. AU - Shaw, M. AU - Messer, R. L. AU - Lockwood, P. E. AU - Hobbs, D. AU - Bouillaguet, S. AU - Sano, H. AU - Lewis, J. B. AU - Wataha, J. C. PY - 2006 DA - 2006// TI - Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1) JO - Toxicol in Vitro VL - 20 UR - https://doi.org/10.1016/j.tiv.2006.01.012 DO - 10.1016/j.tiv.2006.01.012 ID - Omata2006 ER - TY - STD TI - Davis P. Auranofin. Rheum Dis Clin N Am. 1984;10:369–83. ID - ref33 ER - TY - JOUR AU - Furst, D. E. AU - Abruzzo, J. L. AU - Katz, W. A. AU - Dahl, S. L. AU - Ward, J. R. PY - 1983 DA - 1983// TI - Mechanism of action, pharmacology, clinical efficacy and side-effects of auranofin - an orally-administered organic gold compound for the treatment of rheumatoid-arthritis JO - Pharmacotherapy VL - 3 UR - https://doi.org/10.1002/j.1875-9114.1983.tb03277.x DO - 10.1002/j.1875-9114.1983.tb03277.x ID - Furst1983 ER - TY - JOUR AU - Steplewski, Z. AU - Jeglum, K. A. AU - Rosales, C. AU - Weintraub, N. PY - 1987 DA - 1987// TI - Canine lymphoma-associated antigens defined by murine monoclonal antibodies JO - Cancer Immunol Immunother VL - 24 UR - https://doi.org/10.1007/BF00205629 DO - 10.1007/BF00205629 ID - Steplewski1987 ER - TY - JOUR AU - Rutgen, B. C. AU - Hammer, S. E. AU - Gerner, W. AU - Christian, M. AU - de Arespacochaga, A. G. AU - Willmann, M. AU - Kleiter, M. AU - Schwendenwein, I. AU - Saalmuller, A. PY - 2010 DA - 2010// TI - Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma JO - Leuk Res VL - 34 UR - https://doi.org/10.1016/j.leukres.2010.01.021 DO - 10.1016/j.leukres.2010.01.021 ID - Rutgen2010 ER - TY - JOUR AU - Kisseberth, W. C. AU - Nadella, M. V. P. AU - Breen, M. AU - Thomas, R. AU - Duke, S. E. AU - Murahari, S. AU - Kosarek, C. E. AU - Vernau, W. AU - Avery, A. C. AU - Burkhard, M. J. PY - 2007 DA - 2007// TI - A novel canine lymphoma cell line: a translational and comparative model for lymphoma research JO - Leuk Res VL - 31 UR - https://doi.org/10.1016/j.leukres.2007.04.003 DO - 10.1016/j.leukres.2007.04.003 ID - Kisseberth2007 ER - TY - JOUR AU - Suter, S. E. AU - Chein, M. B. AU - von Messling, V. AU - Yip, B. AU - Cattaneo, R. AU - Vernau, W. AU - Madewell, B. R. AU - London, C. A. PY - 2005 DA - 2005// TI - In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1944 DO - 10.1158/1078-0432.CCR-04-1944 ID - Suter2005 ER - TY - STD TI - O'Donoghue LE, Rivest JP, Duval DL. Polymerase chain reaction-based species verification and microsatelite analysis for canine cell line validation. J Vet Diagn Investig. 2011;23:780–5. ID - ref39 ER - TY - JOUR AU - Chou, T. C. PY - 2006 DA - 2006// TI - Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies JO - Pharmacol Rev VL - 58 UR - https://doi.org/10.1124/pr.58.3.10 DO - 10.1124/pr.58.3.10 ID - Chou2006 ER - TY - JOUR AU - Blocka, K. L. N. AU - Paulus, H. E. AU - Furst, D. E. PY - 1986 DA - 1986// TI - Clinical pharmacokinetics of oral and injectable gold compounds JO - Clin Pharmacokinet VL - 11 UR - https://doi.org/10.2165/00003088-198611020-00003 DO - 10.2165/00003088-198611020-00003 ID - Blocka1986 ER - TY - JOUR AU - Lu, J. AU - Holmgren, A. PY - 2012 DA - 2012// TI - Thioredoxin system in cell death progression JO - Antioxid Redox Signal VL - 17 UR - https://doi.org/10.1089/ars.2012.4650 DO - 10.1089/ars.2012.4650 ID - Lu2012 ER - TY - JOUR AU - Matsuzawa, A. PY - 2017 DA - 2017// TI - Thioredoxin and redox signaling: roles of the thioredoxin system in control of cell fate JO - Arch Biochem Biophys VL - 617 UR - https://doi.org/10.1016/j.abb.2016.09.011 DO - 10.1016/j.abb.2016.09.011 ID - Matsuzawa2017 ER - TY - JOUR AU - Chio, I. I. C. AU - Tuveson, D. A. PY - 2017 DA - 2017// TI - ROS in cancer: the burning question JO - Trends Mol Med VL - 23 UR - https://doi.org/10.1016/j.molmed.2017.03.004 DO - 10.1016/j.molmed.2017.03.004 ID - Chio2017 ER - TY - JOUR AU - Keller, E. T. AU - Macewen, E. G. AU - Rosenthal, R. C. AU - Helfand, S. C. AU - Fox, L. E. PY - 1993 DA - 1993// TI - Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma JO - J Vet Intern Med VL - 7 UR - https://doi.org/10.1111/j.1939-1676.1993.tb01021.x DO - 10.1111/j.1939-1676.1993.tb01021.x ID - Keller1993 ER - TY - JOUR AU - Chun, R. AU - Garrett, L. D. AU - Vail, D. M. PY - 2000 DA - 2000// TI - Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma JO - J Vet Intern Med VL - 14 UR - https://doi.org/10.1111/j.1939-1676.2000.tb02224.x DO - 10.1111/j.1939-1676.2000.tb02224.x ID - Chun2000 ER - TY - STD TI - Vail DM. Rescue therapy for canine lymphoma. In: Bonaqura JD, Twedt DC, editors. Kirk’s current veterinary therapy XV. St. Louis: Elsevier; 2013. pp. 381–3. ID - ref47 ER - TY - JOUR AU - Roder, C. AU - Thomson, M. J. PY - 2015 DA - 2015// TI - Auranofin: repurposing an old drug for a golden new age JO - Drugs R D VL - 15 UR - https://doi.org/10.1007/s40268-015-0083-y DO - 10.1007/s40268-015-0083-y ID - Roder2015 ER - TY - JOUR AU - Trachootham, D. AU - Alexandre, J. AU - Huang, P. PY - 2009 DA - 2009// TI - Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? JO - Nat Rev Drug Discov VL - 8 UR - https://doi.org/10.1038/nrd2803 DO - 10.1038/nrd2803 ID - Trachootham2009 ER - TY - JOUR AU - Tome, M. E. AU - Johnson, D. B. F. AU - Rimsza, L. M. AU - Roberts, R. A. AU - Grogan, T. M. AU - Miller, T. P. AU - Oberley, L. W. AU - Briehl, M. M. PY - 2005 DA - 2005// TI - A redox signature score identifies diffuse large B-cell lymphorna patients with a poor prognosis JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-02-0487 DO - 10.1182/blood-2005-02-0487 ID - Tome2005 ER - TY - JOUR AU - Peroja, P. AU - Pasanen, A. K. AU - Haapasaari, K. -. M. AU - Jantunen, E. AU - Soini, Y. AU - Turpeenniemi-Hujanen, T. AU - Bloigu, R. AU - Lilja, L. AU - Kuittinen, O. AU - Karihtala, P. PY - 2012 DA - 2012// TI - Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma JO - Exp Hematol Oncol VL - 1 UR - https://doi.org/10.1186/2162-3619-1-2 DO - 10.1186/2162-3619-1-2 ID - Peroja2012 ER - TY - JOUR AU - Tome, M. E. AU - Frye, J. B. AU - Coyle, D. L. AU - Jacobson, E. L. AU - Samulitis, B. K. AU - Dvorak, K. AU - Dorr, R. T. AU - Briehl, M. M. PY - 2012 DA - 2012// TI - Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance JO - Exp Ther Med VL - 3 UR - https://doi.org/10.3892/etm.2012.487 DO - 10.3892/etm.2012.487 ID - Tome2012 ER - TY - JOUR AU - Jungwirth, U. AU - Kowol, C. R. AU - Keppler, B. K. AU - Hartinger, C. G. AU - Berger, W. AU - Heffeter, P. PY - 2011 DA - 2011// TI - Anticancer activity of metal complexes: involvement of redox processes JO - Antioxid Redox Signal VL - 15 UR - https://doi.org/10.1089/ars.2010.3663 DO - 10.1089/ars.2010.3663 ID - Jungwirth2011 ER - TY - JOUR AU - Gandin, V. AU - Fernandes, A. P. AU - Rigobello, M. P. AU - Dani, B. AU - Sorrentino, F. AU - Tisato, F. AU - Björnstedt, M. AU - Bindoli, A. AU - Sturaro, A. AU - Rella, R. PY - 2010 DA - 2010// TI - Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase JO - Biochem Pharmacol VL - 79 UR - https://doi.org/10.1016/j.bcp.2009.07.023 DO - 10.1016/j.bcp.2009.07.023 ID - Gandin2010 ER - TY - JOUR AU - Liu, N. AU - Li, X. AU - Huang, H. AU - Zhao, C. AU - Liao, S. AU - Yang, C. AU - Liu, S. AU - Song, W. AU - Lu, X. AU - Lan, X. PY - 2014 DA - 2014// TI - Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth JO - Oncotarget VL - 5 ID - Liu2014 ER - TY - JOUR AU - Fiskus, W. AU - Saba, N. AU - Shen, M. AU - Ghias, M. AU - Liu, J. AU - Das Gupta, S. AU - Chauhan, L. AU - Rao, R. AU - Gunewardena, S. AU - Schorno, K. PY - 2014 DA - 2014// TI - Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-2033 DO - 10.1158/0008-5472.CAN-13-2033 ID - Fiskus2014 ER -